BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27783555)

  • 1. Integrated Pharmacies at Community Mental Health Centers: Medication Adherence and Outcomes.
    Wright WA; Gorman JM; Odorzynski M; Peterson MJ; Clayton C
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1330-1336. PubMed ID: 27783555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Database Study Comparing Diabetes-Related Medication Adherence and Health Outcomes for Mail-Order Versus Community Pharmacy.
    Schwab P; Racsa P; Rascati K; Mourer M; Meah Y; Worley K
    J Manag Care Spec Pharm; 2019 Mar; 25(3):332-340. PubMed ID: 30816817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Medication Adherence Among Pharmacies Participating in a North Carolina Enhanced Services Network.
    Urick BY; Bhosle M; Farley JF
    J Manag Care Spec Pharm; 2020 Jun; 26(6):718-722. PubMed ID: 32463769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not.
    Chang HY; Kan HJ; Shermock KM; Alexander GC; Weiner JP; Kharrazi H
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1282-1290. PubMed ID: 32996394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
    Desai V; Nau D; Conklin M; Heaton PC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics.
    Lester CA; Mott DA; Chui MA
    J Manag Care Spec Pharm; 2016 Jul; 22(7):801-7. PubMed ID: 27348281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.
    Peaslee A; Wickizer M; Olson J; Topp R
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons Learned from Using Global Outcome Measures to Assess Community Pharmacy Performance.
    Urick BY; Ferreri SP; Shasky C; Pfeiffenberger T; Trygstad T; Farley JF
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1278-1283. PubMed ID: 30479196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Employer-Sponsored Onsite Pharmacy and Condition Management Programs on Medication Adherence.
    Aguilar KM; Hou Q; Miller RM
    J Manag Care Spec Pharm; 2015 Aug; 21(8):670-7. PubMed ID: 26233539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
    Leslie RS; Gilmer T; Natarajan L; Hovell M
    J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
    Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
    J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics.
    Yehoshua A; Chancellor M; Vasavada S; Malone DC; Armstrong EP; Joshi M; Campbell K; Pulicharam R
    J Manag Care Spec Pharm; 2016 Apr; 22(4):406-13. PubMed ID: 27023694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the ExactCare medication care management model on adherence, health care utilization, and costs.
    Shetty KD; Chen AY; Rose AJ; Liu HH
    J Manag Care Spec Pharm; 2021 May; 27(5):574-585. PubMed ID: 33560167
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of an Academic-Community Partnership to Implement MTM Services in Rural Communities to Improve Pharmaceutical Care for Patients with Diabetes and/or Hypertension.
    Johnson M; Jastrzab R; Tate J; Johnson K; Hall-Lipsy E; Martin R; Taylor AM; Warholak T
    J Manag Care Spec Pharm; 2018 Feb; 24(2):132-141. PubMed ID: 29384026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency.
    Latremouille-Viau D; Guerin A; Gagnon-Sanschagrin P; Dea K; Cohen BG; Joseph GJ
    J Manag Care Spec Pharm; 2017 Feb; 23(2):214-224. PubMed ID: 28125373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.